|
Lenvatinib Pharmevid 4 mg cps dur 30x1x4 mg (blis.OPA/Al/PVC/PE/Al - jednotk.bal.)
4 mg
|
Tvrdá kapsula |
L01EX08
|
Pharmevid s.r.o. |
—
|
|
Lenvatinib Pharmevid 4 mg cps dur 30x4 mg (blis.OPA/Al/PVC/Al)
4 mg
|
Tvrdá kapsula |
L01EX08
|
Pharmevid s.r.o. |
—
|
|
Lenvatinib Pharmevid 4 mg cps dur 30x4 mg (blis.OPA/Al/PVC/PE/Al)
4 mg
|
Tvrdá kapsula |
L01EX08
|
Pharmevid s.r.o. |
—
|
|
Lenvatinib Pharmevid 4 mg cps dur 60x1x4 mg (blis.OPA/Al/PVC/Al - jednotk.bal.)
4 mg
|
Tvrdá kapsula |
L01EX08
|
Pharmevid s.r.o. |
—
|
|
Lenvatinib Pharmevid 4 mg cps dur 60x1x4 mg (blis.OPA/Al/PVC/PE/Al - jednotk.bal.)
4 mg
|
Tvrdá kapsula |
L01EX08
|
Pharmevid s.r.o. |
—
|
|
Lenvatinib Pharmevid 4 mg cps dur 60x4 mg (blis.OPA/Al/PVC/Al)
4 mg
|
Tvrdá kapsula |
L01EX08
|
Pharmevid s.r.o. |
—
|
|
Lenvatinib Pharmevid 4 mg cps dur 60x4 mg (blis.OPA/Al/PVC/PE/Al)
4 mg
|
Tvrdá kapsula |
L01EX08
|
Pharmevid s.r.o. |
—
|
|
Lenvatinib Pharmevid 4 mg cps dur 90x1x4 mg (blis.OPA/Al/PVC/Al - jednotk.bal.)
4 mg
|
Tvrdá kapsula |
L01EX08
|
Pharmevid s.r.o. |
—
|
|
Lenvatinib Pharmevid 4 mg cps dur 90x1x4 mg (blis.OPA/Al/PVC/PE/Al - jednotk.bal.)
4 mg
|
Tvrdá kapsula |
L01EX08
|
Pharmevid s.r.o. |
—
|
|
Lenvatinib Pharmevid 4 mg cps dur 90x4 mg (blis.OPA/Al/PVC/Al)
4 mg
|
Tvrdá kapsula |
L01EX08
|
Pharmevid s.r.o. |
—
|
|
Lenvatinib Pharmevid 4 mg cps dur 90x4 mg (blis.OPA/Al/PVC/PE/Al)
4 mg
|
Tvrdá kapsula |
L01EX08
|
Pharmevid s.r.o. |
—
|
|
Gevesla 100 mg cps mol 30x1x100 mg (blis. OPA/Al/PVC/Al) - jednotk.bal.
100 mg
|
Mäkká kapsula |
L01EX09
|
Sandoz Pharmaceuticals d.d. |
—
|
|
Gevesla 100 mg cps mol 60x1x100 mg (blis. OPA/Al/PVC/Al) - jednotk.bal.
100 mg
|
Mäkká kapsula |
L01EX09
|
Sandoz Pharmaceuticals d.d. |
—
|
|
Gevesla 150 mg cps mol 30x1x150 mg (blis. OPA/Al/PVC/Al) - jednotk.bal.
150 mg
|
Mäkká kapsula |
L01EX09
|
Sandoz Pharmaceuticals d.d. |
—
|
|
Gevesla 150 mg cps mol 60x1x150 mg (blis. OPA/Al/PVC/Al) - jednotk.bal.
150 mg
|
Mäkká kapsula |
L01EX09
|
Sandoz Pharmaceuticals d.d. |
—
|
|
Nintedanib STADA 100 mg cps mol 30x1x100 mg (blis. OPA/Al/PVC/Al) - jednotk.bal.
100 mg
|
Mäkká kapsula |
L01EX09
|
STADA Arzneimittel AG |
—
|
|
Nintedanib STADA 100 mg cps mol 60x1x100 mg (blis. OPA/Al/PVC/Al) - jednotk.bal.
100 mg
|
Mäkká kapsula |
L01EX09
|
STADA Arzneimittel AG |
—
|
|
Nintedanib STADA 150 mg cps mol 30x1x150 mg (blis. OPA/Al/PVC/Al) - jednotk.bal.
150 mg
|
Mäkká kapsula |
L01EX09
|
STADA Arzneimittel AG |
—
|
|
Nintedanib STADA 150 mg cps mol 60x1x150 mg (blis. OPA/Al/PVC/Al) - jednotk.bal.
150 mg
|
Mäkká kapsula |
L01EX09
|
STADA Arzneimittel AG |
—
|
|
Nintedanib Teva 100 mg mäkké kapsuly cps mol 30x1x100 mg (blis.OPA/Al/PVC/Alu- jednotk.bal.)
100 mg
|
Mäkká kapsula |
L01EX09
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Nintedanib Teva 100 mg mäkké kapsuly cps mol 60x1x100 mg (blis.OPA/Al/PVC/Alu - jednotk.bal.)
100 mg
|
Mäkká kapsula |
L01EX09
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Nintedanib Teva 150 mg mäkké kapsuly cps mol 30x1x150 mg (blis.OPA/Al/PVC/Alu- jednotk.bal.)
150 mg
|
Mäkká kapsula |
L01EX09
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Nintedanib Teva 150 mg mäkké kapsuly cps mol 60x1x150 mg (blis.OPA/Al/PVC/Alu- jednotk.bal.)
150 mg
|
Mäkká kapsula |
L01EX09
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Puqod 100 mg mäkké kapsuly cps mol 30x1x100 mg (blis.OPA/Al/PVC/Al-jednotk.bal.)
100 mg
|
Mäkká kapsula |
L01EX09
|
Zentiva, k.s. |
—
|